Individuals with Down syndrome (DS) represent the largest population of genetically determined Alzheimer’s disease (AD).1 This genetic form of AD is driven by triplication of chromosome 21, which encodes the gene responsible for amyloid precursor protein production, leading to beta-amyloid (Aβ) plaque deposition early in life. The gene discussed is APP; the disease is Alzheimer disease.